Aims This study sought to assess the effect of treatment of sacubitril/valsartan (S/V) on
improving cardiac function and reversing cardiac remodelling in patients with acute coronary …

Objective To systematically review the efficacy and safety of sacubitril and valsartan in
treating acute myocardial infarction complicated with heart failure and to observe whether it …

Purpose: To systematically assess the efficacy and safety of sacubitril/valsartan (SV) by
comparison with angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin receptor …

Background Sacubitril–valsartan has been widely reported for reducing the risk of
cardiovascular death and improving left ventricular remodeling in patients with heart failure …

Objective The aim of this study was to investigate the effect of sacubitril/valsartan (Sal/Val)
on left ventricular (LV) remodeling in patients with LV systolic dysfunction following acute …

Background Literature describing recovery of left ventricular (LV) function post
sacubitril/valsartan treatment and the optimal management of heart failure (HF) patients …

Background Sacubitril/valsartan is an angiotensin receptor–neprilysin inhibitor indicated for
the treatment of patients with chronic heart failure (HF) with reduced ejection fraction; …

Aims We aimed to investigate whether sacubitril–valsartan could further improve the
prognosis, cardiac function, and left ventricular (LV) remodelling in patients following acute …

There is limited data on the effect of sacubitril-valsartan on the echocardiographic
parameters in acute decompensated heart failure (ADHF). We prospectively enrolled 68 …

Aims Although the beneficial effect of sacubitril/valsartan (SAC/VAL) compared to enalapril
was consistent across ischaemic cardiomyopathy (ICM) and non-ischaemic cardiomyopathy …